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Optimized genotyping method for identification of bacterial 
contaminants in pharmaceutical industry
Microbiological control is of crucial importance in the 
pharmaceutical industry regarding the possible bacterial 
contamination of the environment, water, raw materials 
and finished products. Molecular identification of bacterial 
contaminants based on DNA sequencing of the hypervari-
able 16SrRNA gene has been introduced recently. The aim 
of this study is to investigate the suitability of gene se-
quencing using our selection of PCR primers and condi-
tions for rapid and accurate bacterial identification in phar-
maceutical industry quality control.
DNA was extracted from overnight incubated colonies 
from 10 bacterial ATCC strains, which are common contami-
nants in the pharmaceutical industry. A region of bacterial 
16SrRNA gene was analyzed by bidirectional DNA se-
quencing. Bacterial identification based on partial sequenc-
ing of the 16SrRNA gene is the appropriate method that 
could be used in the pharmaceutical industry after ade-
quate validations. We have successfully identified all tested 
bacteria with more than 99 % similarity to the already pub-
lished sequences.
Keywords: 16SrRNA, genotyping, bacterial identification, 
pharmaceutical industry
Bacterial contamination of pharmaceutical products is one of the main reasons for 
their recall from the market (1). In the case of suspicious contamination, and in order to 
find its origin, identification of the bacterial species level is mandatory for sterile produc-
tion failure spotting and is important for the production environment, raw materials, 
pharmaceutical water or the release of the finished non-sterile products onto the market.
Morphological and biochemical determination of an unknown microorganism is tra-
ditionally given through pharmacopoeial tests. Recently, different state-of-the-art meth-
ods for bacterial identification have emerged; they include instrumental complex biochem-
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patterns, matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry 
(MAlDI-TOF MS) and genotyping of the 16SrRNA sequence (2, 3).
Although all these methods have their advantages and disadvantages, DNA sequenc-
ing of the bacterial genome region, including the 16SrRNA gene, are evidently becoming 
the gold standard overcoming the majority of other identification techniques (4). These 
genotyping-based methods have a very favorable cost-benefit ratio, particularly consider-
ing the ongoing downward cost trend of DNA sequencing. Namely, the 16SrRNA gene is 
evolutionary conserved in bacterial genomes and very slight variation in the nucleotide 
sequence between different species is used for the identification named ribotyping. In ad-
dition, ribotyping is used for establishing the phylogenetic connections between the spe-
cies (5).
Genotyping of the 16SrRNA gene involves polymerase chain reaction (PCR)-based 
amplification and automated DNA sequencing. Considering that the pair of oligonucle-
otide primers determines the exact amplification region, primer selection is crucial for the 
overall identification success (6). Furthermore, the primers could be selected to be species-
specific, group-specific or universal amplifying almost any bacterial species.
The aim of this study was to investigate the suitability of partial 16SrRNA gene se-
quencing with our optimization of amplification with selected oligonucleotide primers for 
the purpose of rapid and accurate bacterial identification in the pharmaceutical industry.
eXPeRIMeNTAl
Strains preparation
A total of 10 bacteria (4 Gram-positive, 5 Gram-negative and one Gram-positive to 
Gram-variable) from the American Type Culture Collection (ATCC) were used in the 
study. The following strains were used: Escherichia coli ATCC 8739, Pseudomonas aeruginosa 
ATCC 9027, Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Sal­
monella typhimurium ATCC 14028, Enterococcus faecalis ATCC 29212, Burkholderia cepacia 
ATCC 25416, Bacillus subtilis subsp. spizizenii ATCC 6633, Proteus mirabilis ATCC 12453, Ko­
curia rhizophila ATCC 9341. These bacterial strains (kWIk-STIk™, Microbiologics, Micro-
biologics, Inc., Saint Cloud, uSA), were inoculated on Trypcase soy agar (TSA, bioMérieux, 
France) and incubated overnight. A loop-full of colonies from the second passage, also 
incubated overnight, was used for DNA isolation.
DNA Isolation
DNA was extracted using the Genelute™ Bacterial Genomic DNA kit (Sigma-Aldrich, 
uSA) according to the manufacturer’s instructions.
PCR amplification of 16SrRNA gene
For oligonucleotide primer pair selection, in silico analysis was performed using the 
nucleotide sequence data from the specialized ribosomal RNA Database, Silva, release 119 
(7). Modified touchdown amplification was performed using 1 U AmpliTaq Gold Poly-
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merase (Applied Biosystems, uSA) per reaction, 2.5 mmol l–1 MgCl2, 200 µmol l–1 dNTPs, 
0.4 µmol l–1 of each forward primer 5’-TGG AGA GTT TGA TCC TGG CTC AG-3’ and re-
verse primer 5’-TAC CGC GGC TGC TGG CAC-3’ on a GeneAmp System 2400 thermocy-
cler (Perkin elmer, uSA). Those primers were previously described by hall et al. (2), Gomez 
et al. (8), and Nawaz and Ahmed (3). After initial denaturation at 94 °C for 3 min, a total of 
37 cycles were used, each performed at 94 °C for 1 min, 62 °C for 30 s, 72 °C for 3 min. (2 
cycles) and then the annealing temperature was reduced for each consecutive cycle by 1 
°C up to 50 °C. After completion, a final extension was performed at 72 °C for 5 min. The 
PCR products were purified using the standard sodium acetate/ethanol protocol (9).
Negative controls were included in each experiment to verify the absence of con-
taminant bacterial DNA in PCR reagent or consumables.
Sequencing
Cycle sequencing was performed using the BigDye cycle sequencing kit v3.1 (Applied 
Biosystems, uSA) on an ABI Prism Genetic Analyzer 310 (Perkin elmer) according to the 
manufacturer's instructions. All sequencing experiments were performed twice on two 
different occasions.
Sequence data analysis
Sequence readings were manually verified using the Sequence Scanner software 2 ver. 
2.0 (Applied Biosystems, uSA). For each bacterial strain, the 16SrRNA gene sequence was 
created from both sequencing data (5’ and 3’) using the Bioedit Sequence Alignment editor 
ver. 7.2.5 (10) and was trimmed to a length of 500 base pairs (bp). The percent of both 
similarity and divergence between 16SrRNA gene sequence for each of the ten ATCC bac-
terial strains used in the study was calculated using the iterative type of pairwise align-
ment by Similarity analyses and Distance Matrix, option of BioEdit software v.7.2.5 (Tom 
hall, Ibis Biosciences, Carlsbad, California, uSA), respectively.
Identification of bacterial species was performed by comparing the obtained sequenc-
es with all available similar sequences in the GeneBank database using the nucleotide 
BlAST on-line analysis in the NCBI GeneBank database (11).
ReSulTS AND DISCuSSION
We have isolated genomic DNA from each of the ten bacterial strains and amplified it 
using modified touch-down PCR producing amplicons with the size range between 500 
and 550 bp (Fig. 1).
using DNA sequencing of the amplicons with both forward and reverse primers and 
subsequent nucleotide BLAST analysis, we have unambiguously identified all ATCC iso-
lates to the species and/or subspecies level. The BlAST’s identity score characterizes the 
percent of alignment of identical nucleotides between the submitted (query) and the data-
base DNA sequences. In our experiments, this score was greater than 99 % for all ten spe-
cies, signifying the similarity of our 16SrRNA gene sequences to the sequences already 
published in the NCBI nucleotide database (Table I).
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In order to evaluate further the informativeness of the obtained 16SrRNA gene sequenc-
es for ribotyping-based identification, similarity/divergence calculations were performed 
between the 10 bacterial species and presented in the diagonal matrix format (Table II).
It is obvious that the bacterial species belonging to the same genus have a higher 
percent of similarity: S. aureus and S. epidermidis from genus Staphylococcus (82.6 %), while 
the percent of divergence is very low (2.7 %). In addition, comparison of the values from 
different species (E. coli and S. typhimurium) of the same family (Enterobacteriaceae), reveals 
a very high percentage of similarity (91.2 %) and low divergence (4.1 %).
Fig. 1. Electrophoretic profile of PCR-amplified bacterial 16SrRNA gene from each isolate. The ampli-
fied DNA was resolved by agarose gel-electrophoresis.
M – molecular mass marker,  1 – E. coli, 2 – P. aeruginosa, 3 – S. aureus, 4 – S. epidermidis, 5 – S. typhi­
murium, 6 – E. faecalis, 7 – B. cepacia, 8 – B. subtilis sub. spiz., 9 – P. mirabilis, 10 – K. rhizophila.
Table I. Results of the BLAST analysis of the nucleotide sequences of bacteria 







E. coli ATCC 8739 Escherichia coli strain ST540   99 917 9384 CP007390.1
P. aeruginosa Pseudomonas aeruginosa strain CB3   99 898   898 kJ854401.1
S. aureus Staphylococcus aureus subsp. aureus strain ATCC 25923 100 924 5546 CP009361.1
S. epidermidis Staphylococcus epidermidis strain F2a 100 924   924 kM052202.1
Salmonella enterica  
subsp. enterica Salmonella enterica subsp. enterica   99 904 6282 CP008928.1
E. faecalis Enterococcus faecalis ATCC 29212   99 911 3646 CP008816.1
B. cepacia Burkholderia cepacia strain ATCC 25416 100 924   924 NR_114491.1
B. subtilis subsp. 
spizizenii
Bacillus subtilis subsp. spizizenii 
strain NRS 231 100 902 7201 CP010434.1
P. mirabilis Proteus mirabilis strain FBh-1 100 924   924 kJ619638.1
K. rhizophila Kocuria rhizophila isolate le 78   99 913   913 FN908446.1
Only the most relevant hit is presented: the one with the highest identity score (%), max. score and total score.
a Score of single best aligned sequence.
b Sum of scores of all aligned sequences. This score indicates that there is more than one part of the sequence that 
is aligned with the unknown sequence.
c unique number linked to the GeneBank record.
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These results suggest that even in the philogenetically close bacteria, there are suffi-
cient divergent nucleotides to be used for species identification in our modification of 
16SrRNA genotyping. According to the presented data, this is applicable for evolutionary 
distant organisms such as K. rhizophila from phylum Actinobacteria displaying a relatively 
high divergence (28.8 %) from S. typhimurium from phylum Proteobacteria.
Genotyping of bacterial 16SrRNA gene is becoming a mainstream in microbiological 
quality control in the pharmaceutical industry, surpassing the biochemistry-based and 
traditional cultivation methods for bacterial identification. Many ribotyping methods have 
been described for different purposes including, but not limited to, clinical, ecological and 
phylogenetical identification of bacteria.
We have evaluated the suitability of our modified ribotyping method for its potential 
use in pharmaceutical quality control. One of the most critical components for PCR ampli-
fication is the primer pair selection. Each of the two oligonucleotide primers should anneal 
to the highly conserved sites of the bacterial 16SrRNA gene flanking the hypervariable 
gene sequence. We have performed extensive in silico analysis of the bacterial 16SrRNA 
gene database searching for primer pairs that could anneal most efficiently yet amplifying 
most of the variable sequence, hence enabling identification of as many as possible bacte-
rial species. however, the pair of oligonucleotide primers that meet those criteria most 
efficiently was already published in the literature for other purposes (2, 3, 8). An almost 
identical primer sequence was originally described for detection of Mycobacteria in medical 
diagnostics (2, 12), as well as for molecular detection of different Gram-positive and Gram-
negative, anaerobic or aerobic bacteria in clinical samples (8). In addition, the same pair of 
primers was used for amplification of DNA from unknown species of luminescent marine 
bacteria (3). This led us to the presumption that the same primers would be appropriate 
for identification of bacterial contaminants in pharmaceutical quality control samples. Ten 




1 2 3 4 5 6 7 8 9 10
E. coli  83.2 72.3 62.5 91.2 69.7 78.3 70.9 88.4 62.1
P. aeruginosa 14.3  72.9 65.3 78.1 68.8 81.4 73.1 83.4 62.7
S. aureus 27.0 22.7  82.6 72.1 80.6 71.0 86.8 70.4 65.7
S. epidermidis 26.4 24.3   2.7  60.0 67.9 62.8 74.8 63.6 71.6
S. typhimurium   4.1 15.6 23.9 27.3  70.1 75.3 69.8 83.7 63.2
E. faecalis 24.9 24.9 16.5 17.7 25.4  69.7 80.5 68.4 64.8
B. cepacia 21.4 17.9 26.4 29.6 19.5 25.7  72.3 78.9 65.4
B. subtilis sub. spiz. 26.9 23.4 11.6 12.2 26.4 16.0 26.8  70.7 66.9
P. mirabilis   8.5 14.5 25.3 28.2   9.8 26.3 22.7 28.8  63.4
K. rhizophila 27.5 27.4 27.6 23.9 28.8 26.7 21.9 26.0 26.3  
1 2 3 4 5 6 7 8 9 10
 Sequence divergence (%)
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phylogenetically distant selected bacterial species from our study are used as test strains 
in many analytical applications (13) and are frequent contaminants in the manufacturing 
of pharmaceuticals (1).
While some authors emphasize that lack of sufficient sequence variations in 16SrRNA 
gene between some closely related species, e.g. in the genus Bacillus (14), could limit the 
usefulness of ribotyping, other studies have shown that only one nucleotide difference in 
the 16SrRNA gene is enough to distinguish between B. cereus and B. anthracis species (15). 
Our study also supports the conclusion that ribotyping of a partial sequence of this gene 
provides enough information for discrimination on even the subspecies level (subtypes 
and similar taxons). Considering the same genus, we have unambiguously allotted the B. 
subtilis strain to the subspecies level spizizenii.
CONCluSIONS
The region of the 16SrRNA gene that we have amplified and sequenced has provided 
sufficient information for unambiguous identification of the ATCC strains at the species 
and subspecies level, with more than 99 % of sequence similarity to the already published 
sequences in the NCBI nucleotide database using BlAST analysis.
Sequence analyses of ten bacteria revealed that the nucleotide variations were ade-
quate for identification of both phylogenetically related and distant bacteria with our 
modification of 16SrRNA genotyping. Bacterial identification based on partial sequencing 
of the 16SrRNA gene is a reliable, fast and very accurate method, which could be used in 
quality control of pharmaceuticals after adequate method validation. In contrast to classi-
cal microbiology, this molecular testing does not require viable bacteria, time-consuming 
cultivation or problematic identification of slow-growing and difficult-to-cultivate organ-
isms.
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